Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer

for
Triple Negative Breast Cancer (TNBC),
Location: Toronto, Houston TX, San Antonio TX,
Sponsor: ProteinQure Inc.

Sex: All

Age: 18+

Code: NCT07190469

Phase 1, Recruiting

Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

for
Advanced Cancers (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Mets) With Specific Mutations (Homologous Recombination Deficiency),
Location: New Haven CT, New York NY, Houston TX, Sacramento CA
Sponsor: Duke Street Bio Ltd

Sex: All

Age: 18+

Code: NCT06458712

Phase 1, Recruiting

Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy

for
Cancer
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT07354100

Phase 1, Phase 2, Recruiting

Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies

for
Cancer
Location: Houston TX
Sponsor: The Methodist Hospital Research Institute

Sex: All

Age: 18+

Code: NCT07290491

Phase 3, Recruiting

Evaluation of a Mobile App Program for Coping With Cancer

for
Cancer
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06923501

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Human Observatory Study

for
Aging, Mortality, All-cause Mortality, Life Expectancy,
Location: Boulder CO
Sponsor: Longevity Metrics, Inc.

Sex: All

Age: 18+

Code: NCT07646782

Recruiting

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

for
Metastatic Cancer, Neoplasm, Prostate, Castrate-sensitive,
Location: The Bronx NY, New York NY, Wappingers Falls NY,
Sponsor: Sun Pharmaceutical Industries Limited

Sex: Male

Age: 18+

Code: NCT05422911

Phase 2, Recruiting

High-Resolution PET-CT Imaging for Surgical Margin Visualization

for
Cancer, Solid Malignant Tumors, SCC - Squamous Cell Carcinoma,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT06915454

Recruiting

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

for
Renal Cell Carcinoma (RCC),
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT05176483

Phase 1, Recruiting

Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer

for
Locally Advanced Pancreatic Ductal Adenocarcinoma (PDA)
Location: Philadelphia PA
Sponsor: Fox Chase Cancer Center

Sex: All

Age: 18+

Code: NCT06984562

Recruiting

Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States

for
Hematopoietic Stem Cell Transplantation, Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05681026

Recruiting

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Boston MA, New York NY, Hackensack NJ, Buffalo NY,
Sponsor: NextCure, Inc.

Sex: All

Age: 18+

Code: NCT06792552

Phase 1, Recruiting

A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment

for
Chemotherapy-Induced Peripheral Neuropathy,
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 18+

Code: NCT07365007

Recruiting

Adapting The Fear Of Recurrence Therapy (FORT) for Parents and Establishing Acceptability and Feasibility

for
Cancer, Parent, Fear of Cancer Recurrence, CBT,
Location: Ottawa
Sponsor: University of Ottawa

Sex: All

Age: 18+

Code: NCT06872840

Recruiting

Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention

for
Cancer, Fatigue, Brain Tumor Adult
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18 - 39

Code: NCT07186556

Recruiting

Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia

for
Advanced Malignant Solid Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT04984551

Phase 2, Recruiting

A Study of an IDH1m Inhibitor in Participants With IDH1-Mutated Malignancies and Hepatic or Renal Impairment

for
IDH1-Mutated Malignancies
Location: Atlanta GA, Houston TX
Sponsor: Servier Bio-Innovation LLC

Sex: All

Age: 18+

Code: NCT07006688

Phase 1, Recruiting

A Study of DS5361b in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Providence RI, Fairfax VA, Sarasota FL, Irving TX,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT07182591

Phase 1, Recruiting

Different Types of Massage Therapy to Reduce Anxiety During Chemotherapy Infusion in Patients With Cancer

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Irvine CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07184294

Recruiting

An 8-Week Study Evaluating Gut and Digestive Health After Use of a Dietary Supplement System

for
Gastrointestinal Symptoms, Digestive Health, Gut Health
Location: San Francisco CA
Sponsor: SF Research Institute, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07421596

Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial